>

New Molecule Could Help Restore Memory, Cognition in Alzheimer's Disease

Groundbreaking Research from UCLA Health

A groundbreaking new study from UCLA Health researchers has identified and synthesized a molecule that could potentially restore memory and cognition in Alzheimer's disease patients. The candidate compound, known as PBA, has shown promising results in mice models of the disease, and researchers are now investigating its effects in humans.

PBA's Effects on Alzheimer's-Related Symptoms

In studies conducted on mice that model Alzheimer's disease, injections of PBA helped to restore signs of normal proteostasis, the process by which proteins are folded and processed correctly. This impaired process is a hallmark of Alzheimer's disease.

Potential Implications for Human Treatment

If PBA is found to have similar effects in humans, it could be a novel and effective treatment for Alzheimer's disease. Currently, there are no FDA-approved treatments that can stop or slow the progression of the disease, which affects millions of people worldwide.

Further Research and Clinical Trials

The researchers at UCLA Health are continuing their research to further investigate the effects of PBA and to determine its safety and efficacy in humans. Clinical trials are expected to begin in the near future to assess the potential therapeutic benefit of PBA in Alzheimer's disease patients.